Correlation Between Seres Therapeutics and Neximmune
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Neximmune, you can compare the effects of market volatilities on Seres Therapeutics and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Neximmune.
Diversification Opportunities for Seres Therapeutics and Neximmune
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Seres and Neximmune is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Neximmune go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Neximmune
If you would invest 243.00 in Neximmune on November 5, 2024 and sell it today you would earn a total of 0.00 from holding Neximmune or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Neximmune
Performance |
| Timeline |
| Seres Therapeutics |
| Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Seres Therapeutics and Neximmune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Neximmune
The main advantage of trading using opposite Seres Therapeutics and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |